Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
- Conditions
- MelanomaBreast CancerLymphomaOvarian CancerProstate Cancer
- Registration Number
- NCT00001503
- Lead Sponsor
- National Cancer Institute (NCI)
- Brief Summary
This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.
- Detailed Description
Background:
* Patients enrolled on CCR clinical protocols may require long term follow-up to assess outcome (e.g., survival) or the effects of prior therapy.
* Keeping the primary treatment protocols open after accrual is complete in order to follow patients for long term outcome is an administrative burden on investigators and the IRB.
Objectives:
-To provide follow-up for patients who are long term survivors previously enrolled Center for Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol.
Eligibility:
-Patients who were previously enrolled on a CCR protocol and who are not eligible for an active NCI intramural primary research protocol.
Design:
* The medical procedures/tests will be based on the patient's diagnosis, treatment and supporting clinical information. This is a follow-up study in which only standard tests and procedures are to be performed.
* Clinical information that is relevant to the patients prior protocols will be collected for research purposes.
* Procedures that entail more than minimal risk to the patient should not be performed for research purposes on this protocol.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1031
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To provide follow-up for patients who are long term survivors previously enrolled Center for Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol 30 years Provision of a mechanism to follow selected CCR patients when their protocols have been terminated.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
National Institutes of Health Clinical Center
🇺🇸Bethesda, Maryland, United States